—
Planned Parenthood has found a new scheme to profiting from what they’re calling, “Just In Case Abortion Pills,” in which Planned Parenthood prescribers plan to sell the abortion drug mifepristone (200mg)/Mifeprex to women without a confirmed pregnancy.
Referred to elsewhere as “advance provision” of the abortion pill, the move blatantly rebuffs the Food and Drug Administration’s REMS safety regulations which require prescribers of the drug to have the “ability to assess the duration of pregnancy accurately.”
Key Takeaways
A Planned Parenthood affiliate has announced its plan to launch advance provision abortion pills under the name “Just in Case Abortion Pills.”
This means that, against FDA safety protocols for the drug, the Planned Parenthood Great Northwest, Hawai’i, Alaska, Indiana, Kentucky affiliate will dispense abortion drugs to women who are not even pregnant.
Prescribers of the drug are expected to have the ability to accurately assess the duration of the pregnancy (determining gestational age), but it is clear that dispensing these drugs in advance of a pregnancy is flouting the FDA’s protocols.
The mountain of evidence of the decades of Planned Parenthood’s discrimination, documented Medicaid fraud, HIPAA violations, failure to report child sexual abuse, massive privacy breaches of client data, and now blatantly violating FDA safety protocols, should disqualify it from receiving any taxpayer funds.
The Details:
A news release published by Planned Parenthood Great Northwest, Hawai‘i, Alaska, Indiana, Kentucky (PPGNHAIK) announcing the launch of Just In Case Abortion Pills, claimed the policy change was so women could “have them on hand if and when they need them.” The affiliate added that “PPGNHAIK joins a growing number of sexual and reproductive health care providers offering this model of care.”
Never miss the latest news in the fight for life.
In other words, since everyone else is doing it – so will we.
PPGNHAIK claims it will only offer this option to women 18 years of age or older “through telehealth,” writing (emphases added):
Just In Case Abortion Pills are not emergency contraception… Just In Case Abortion Pills are prescribed for people who may become pregnant and are used after pregnancy occurs. Both are important tools for supporting people in managing their reproductive health. This medication is prescribed for use up to 12 weeks of pregnancy.
Note also that 12 weeks of pregnancy is two weeks past the FDA’s currently approved 10-week limit for the abortion pill.
“[T]his really is the right time for us to step into this space,” Rebecca Gibron, president and CEO of PPGNHAIK told NPR.org.
Dr. Colleen McNicholas, chief of medical affairs at PPGNHAIK, claimed that If a patient gets the pills and then goes to use them 11 months later, “we are still available to them as their provider to answer those questions, to review — how do I know how far along I am? What do we expect?” she told NPR.
The affiliate, which operates facilities in Alaska, Hawaiʻi, Idaho, Indiana, Kentucky, and western Washington, recorded 11,992 abortions committed in 2025.
Reality Check:
→Mifepristone is not FDA-approved for ‘just in case’ provision←
‘Just in case’ provision, along with the previously crafted ‘advance provision’ or ‘missed period pills’ are monikers denoting one more way the abortion industry is flouting the Food and Drug Administration’s (FDA) REMS safety requirements.
To be approved to prescribe the abortion pill (mifepristone 200mg/Mifeprex), prescribers must be able to properly date a pregnancy.
Selling abortion pills ‘just in case’ a woman gets pregnant, in advance of a pregnancy, is clearly ignoring the intent of the FDA’s safety requirement.
The FDA has thus far failed to hold Danco and GenBioPro (the manufacturers) accountable for properly policing their prescribers and decertifying anyone who violates the FDA’s REMS.
Live Action News previously documented how Big Abortion’s media darling, Dr. Daniel Grossman — an abortionist with ties to an organization recently funded by the abortion pill’s manufacturer — promoted the unapproved and dangerous idea that abortionists should dispense the abortion pill to women before they become pregnant.
Grossman’s 2019 “mixed-methods study” was swiftly withdrawn. A reason for the withdrawal was not specified.
Grossman knew then just like Planned Parenthood knows now, that “advance provision” or “just in case” abortion pill dispensing is NOT FDA approved.
Writing in the LA Times in 2018, Grossman acknowledged:
There’s at least one significant obstacle, however. The Food and Drug Administration has not approved abortion pills for advance provision. The agency doesn’t even allow clinicians to prescribe mifepristone, one of the two drugs that make up medication abortion, for pick-up at a pharmacy.
In 2021, Grossman resurrected the idea of ‘advance provision’ in a tweet to his followers, as a solution to the overturn of Roe.
READ: Big Abortion promotes ‘advance provision’ abortion pill, ignores FDA rules and research ethics
In the same Twitter thread, Grossman warned in a somewhat “fine print” tone: “[…]there are some people who are not good candidates… including those taking blood thinners or who have a bleeding disorder.” Grossman later specified that women at risk of ectopic pregnancy and other conditions are not a “good option” either.
However, he didn’t specify how women experiencing a first pregnancy would necessarily know if they were at risk of ectopic pregnancy…
Hemorrhage during the process of expelling the preborn child is a potential complication of the abortion pill regimen.
This is not medical science; this is discarding longstanding FDA requirements to achieve a political end, and at the expense of even women’s safety.
Grossman is a co-author on many of the studies reviewed by the FDA which the agency used under two different administrations to justify removing the in-person dispensing requirement and to erode the REMS to allow mail-order and pharmacy dispensing by 2023.
Stunning lack of oversight
In a hearing with then-FDA Commissioner Dr. Robert Califf before a Senate Agriculture Appropriations Subcommittee on May 8, 2024, Senator Cindy Hyde-Smith stated:
“It has been reported on more than one instance that American women are stockpiling the abortion pills through advanced prescribing through abortion companies and providers. It’s not even approved for that, and they can get it without even seeing a doctor.”
The Senator added:
My husband has a doctor’s appointment… for a sinus medication that he can’t get refilled until he sees a doctor. It blows me away that you can get this with no doctor oversight, and it is a drug that will literally cause you intentionally to have an abortion and end your pregnancy and the life of that child.
Califf was replaced by Dr. Marty Makary as head of FDA, but he recently resigned and was replaced by Acting FDA Commissioner Kyle Diamantas, who has signaled an interest in addressing concerns surrounding the abortion pill.
Still, as NPR reported, “Trump’s FDA has done very little to restrict use of abortion medication thus far, to the frustration of his anti-abortion supporters.”
Why It Matters:
The abortion pill was placed under a safety system to monitor adverse events, which is supposed to be policed by the manufacturers: Danco Laboratories, GenBioPro (GBP), and the latest generic company, Evita Solutions, LLC.
Prescribers who violate the REMS should be de-certified by the manufacturers — but as Live Action News has repeatedly documented, this is not being done.
The intentional strategy to violate FDA safety requirements is reminiscent of the pre-Roe years, when doctors violated the law and committed abortions.
The FDA previously warned that shipping women (or teens) abortion pills in advance of verified pregnancies is risky, despite the fact that media abortion allies advocate for it.
In 2022, Politico wrote, “The FDA said health providers prescribing abortion medication to people who aren’t pregnant are acting without its authorization and that the practice is potentially dangerous for patients.” The outlet also stated (emphases added):
The FDA spokesperson told POLITICO that if mifepristone, which stops the flow of hormones supporting a fetus in the uterus, were prescribed before a patient is pregnant, providers wouldn’t be able to properly oversee care to ensure safety and effectiveness. Abortion medication is regulated more tightly by the FDA than other drugs, restrictin
